• Brabin BJ (1991) The risks and severity of malaria in pregnant women. Applied Field Research in Malaria. Report number 1. UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases. World Health Organization, Geneva. pp. 152. World Health Organization, Geneva, pp. 134.
  • Costedoat-Chalumeau N, Amoura Z, Huong du LT, Lechat P & Piette JC (2005) Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature. Autoimmunity Reviews 4, 111115.
  • Dubowitz L, (ed.) (1977) A Clinical Manual: Gestational Age of the Newborn. Addison Wesley, USA.
  • Haataja L, McGready R, Arunjerdja R et al. (2002) A new approach for neurological evaluation of infants in resource-poor settings. Annals of Tropical Paediatrics 22, 355368.
  • Kayentao K, Kodio M, Newman RD et al. (2005) Comparison of intermittent preventive treatment with chemoprophylaxis for the prevention of malaria during pregnancy in Mali. Journal of Infectious Disease 191, 109116.
  • Levy RA, Vilela VS, Cataldo MJ et al. (2001) Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study. Lupus 10, 401404.
  • McGready R, Simpson J, Panyavudhikrai S et al. (2000) Neonatal neurological testing in resource-poor settings. Annals of Tropical Paediatrics 20, 323336.
  • Mendis K, Sina BJ, Marchesini P & Carter R (2001) The neglected burden of Plasmodium vivax malaria. American Journal of Tropical Medicine and Hygiene 64, 97106.
  • Nosten F, Ter Kuile F, Maelankirri L, Decludt B & White NJ (1991) Malaria during pregnancy in an area of unstable endemicity. Transactions of the Royal Society of Tropical Medicine and Hygiene 85, 424429.
  • Nosten F, McGready R, Simpson JA et al. (1999a) Effects of Plasmodium vivax malaria in pregnancy. Lancet 354, 546549.
  • Nosten F, Vincenti M, Simpson J et al. (1999b) The effects of mefloquine treatment in pregnancy. Clinical Infectious Diseases 28, 808815.
  • Nosten F, Van Vugt M, Price R et al. (2000) Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet 356, 297302.
  • Ostensen M & Ramsey-Goldman R (1998) Treatment of inflammatory rheumatic disorders in pregnancy: what are the safest treatment options? Drug Safety 19, 389410.
  • Parke A (1988) Antimalarial drugs and pregnancy. American Journal of Medicine 85, 3033.
  • Petri M (2003) Immunosuppressive drug use in pregnancy. Autoimmunity 36, 5156.
  • Singh N, Shukla MM & Sharma VP (1999) Epidemiology of malaria in pregnancy in central India. Bulletin of the World Health Organization 77, 567572.